Dr Lynne Daintree

Development Director

Crystec Pharma


Dr Lyn Daintree has extensive knowledge of formulation development using supercritical fluids. Lyn has responsibility for scientific programme management for external client projects, proprietary molecules, compliance, new opportunity assessment and development of intellectual property. Lyn gained her doctorate from the School of Pharmacy at the University of Bradford whilst working for Bradford Particle Design. She subsequently led a team developing new products for Nektar Therapeutics UK Ltd. Her SCF processing experience includes developing methods to control particle size and surface area, chiral separation, polymorph control and generation of stable composite systems. Lyn is an active member of the Royal Society of Chemistry (RSC) and former RSC committee member of the Formulation Science and Technology Group.

« Back